Umer Raffat
Stock Analyst at Evercore ISI
(4.16)
# 1,536
Out of 4,531 analysts
159
Total ratings
51.7%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by Umer Raffat
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PBLS Parabilis Medicines | Initiated Coverage: Buy | n/a | $29.55 | - | 1 | Jul 6, 2026 | |
| SYRE Spyre Therapeutics | Maintained: Buy | n/a | $100.23 | - | 6 | Jun 3, 2026 | |
| PCVX Vaxcyte | Maintained: Buy | n/a | $56.20 | - | 2 | May 21, 2026 | |
| BIIB Biogen | Initiated Coverage: Buy | n/a | $205.99 | - | 8 | May 15, 2026 | |
| KLRA Kailera Therapeutics | Initiated Coverage: Buy | n/a | $18.55 | - | 1 | May 12, 2026 | |
| ELAN Elanco Animal Health | Maintained: Buy | n/a | $25.83 | - | 6 | May 11, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | n/a | $134.28 | - | 15 | May 7, 2026 | |
| LLY Eli Lilly and Company | Maintained: Hold | n/a | $1,179.11 | - | 13 | May 4, 2026 | |
| AMGN Amgen | Maintained: Buy | n/a | $366.29 | - | 17 | May 1, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Hold | n/a | $6.78 | - | 6 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.05 | - | 8 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.52 | - | 7 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $42.64 | - | 3 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $4.87 | +105.34% | 3 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $58.18 | - | 3 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $32.03 | - | 9 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $52.72 | - | 6 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $27.09 | - | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $27.37 | - | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.81 | - | 2 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $18.09 | n/a | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.66 | n/a | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $127.50 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $16.26 | n/a | 1 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $17.75 | n/a | 4 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $10.94 | n/a | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $22.26 | n/a | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $17.29 | n/a | 6 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $247.53 | n/a | 5 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $157.24 | n/a | 3 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.49 | n/a | 2 | Jun 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $18.03 | n/a | 1 | Mar 9, 2018 |
Parabilis Medicines
Jul 6, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $29.55
Upside: -
Spyre Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $100.23
Upside: -
Vaxcyte
May 21, 2026
Maintained: Buy
Price Target: n/a
Current: $56.20
Upside: -
Biogen
May 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $205.99
Upside: -
Kailera Therapeutics
May 12, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $18.55
Upside: -
Elanco Animal Health
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $25.83
Upside: -
Gilead Sciences
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $134.28
Upside: -
Eli Lilly and Company
May 4, 2026
Maintained: Hold
Price Target: n/a
Current: $1,179.11
Upside: -
Amgen
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $366.29
Upside: -
Bausch Health Companies Inc.
Apr 30, 2026
Maintained: Hold
Price Target: n/a
Current: $6.78
Upside: -
Apr 27, 2026
Maintained: Buy
Price Target: n/a
Current: $25.05
Upside: -
Apr 10, 2026
Maintained: Hold
Price Target: n/a
Current: $13.52
Upside: -
Mar 27, 2026
Maintained: Buy
Price Target: n/a
Current: $42.64
Upside: -
Mar 9, 2026
Maintained: Buy
Price Target: $10
Current: $4.87
Upside: +105.34%
Feb 12, 2026
Maintained: Hold
Price Target: n/a
Current: $58.18
Upside: -
Nov 26, 2025
Maintained: Buy
Price Target: n/a
Current: $32.03
Upside: -
Nov 12, 2025
Maintained: Buy
Price Target: n/a
Current: $52.72
Upside: -
Nov 11, 2025
Maintained: Buy
Price Target: n/a
Current: $27.09
Upside: -
Oct 8, 2025
Maintained: Buy
Price Target: n/a
Current: $27.37
Upside: -
Sep 30, 2025
Maintained: Buy
Price Target: n/a
Current: $0.81
Upside: -
May 12, 2025
Maintained: Buy
Price Target: n/a
Current: $18.09
Upside: n/a
Feb 21, 2025
Maintained: Buy
Price Target: n/a
Current: $8.66
Upside: n/a
Feb 5, 2025
Maintained: Buy
Price Target: n/a
Current: $127.50
Upside: n/a
Oct 15, 2024
Upgraded: Buy
Price Target: n/a
Current: $16.26
Upside: n/a
Mar 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $17.75
Upside: n/a
May 11, 2023
Upgraded: Buy
Price Target: n/a
Current: $10.94
Upside: n/a
Nov 1, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $22.26
Upside: n/a
Dec 9, 2021
Maintained: Buy
Price Target: n/a
Current: $17.29
Upside: n/a
Jan 28, 2021
Maintained: Buy
Price Target: n/a
Current: $247.53
Upside: n/a
Jul 20, 2020
Reiterated: Buy
Price Target: n/a
Current: $157.24
Upside: n/a
Jun 4, 2019
Maintained: Buy
Price Target: n/a
Current: $4.49
Upside: n/a
Mar 9, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $18.03
Upside: n/a